Tilray Brands (TLRY) Shares Outstanding (Diluted) (2019 - 2026)
Tilray Brands (TLRY) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 833.33 Mn |
| 10 | Tilray Brands | 541.05 Mn | 306.41 Mn | 90.52 Mn | 111.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 111.83 Mn |
| Feb 28, 2026 | 112.68 Mn |
| Nov 30, 2025 | 110.34 Mn |
| Aug 31, 2025 | 106.03 Mn |
| May 31, 2025 | 89.03 Mn |
| Feb 28, 2025 | 90.83 Mn |
| Nov 30, 2024 | 86.50 Mn |
| Aug 31, 2024 | 87.54 Mn |
| May 31, 2024 | 74.26 Mn |
| Feb 29, 2024 | 75.44 Mn |
| Nov 30, 2023 | 73.08 Mn |
| Aug 31, 2023 | 69.12 Mn |
| May 31, 2023 | 61.80 Mn |
| Feb 28, 2023 | 61.55 Mn |
| Nov 30, 2022 | 61.17 Mn |
| Aug 31, 2022 | 57.53 Mn |
| May 31, 2022 | 48.12 Mn |
| Feb 28, 2022 | 48.85 Mn |
| Nov 30, 2021 | 46.03 Mn |
| Aug 31, 2021 | 44.94 Mn |